Skip to content
Lower risk Drug recall · FDA · Published January 13, 2023

Nephron Sc Recalls Racepinephrine Inhaler Due to Short Fill Hazard

Nephron Sc recalls 30x0.5mL Racepinephrine inhaler vials with short fill risk. This may cause incorrect dosing. Consumers should contact for details.

🇺🇸 FDA recall #D-0176-2023DrugNephron Sc ›
Take action

Contact the company

Recalling firmNephron Sc Inc4500 12th Street Ext · West Columbia, SC 29172-3025
✎ GovInfoNow plain-language explainer

Nephron Sc is recalling 30x0.5 mL Racepinephrine inhaler vials that may have a short fill issue. This could lead to incorrect dosing and potential health risks if used. Read more at govinfonow.com/recall/34003-nephron-sc-recalls-racepinephrine-inhaler-due-to-short-fill-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/34003-nephron-sc-recalls-racepinephrine-inhaler-due-to-short-fill-hazard · Updated August 18, 2026 · FDA enforcement record: FDA #D-0176-2023

Cite this page

“Nephron Sc Recalls Racepinephrine Inhaler Due to Short Fill Hazard.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34003-nephron-sc-recalls-racepinephrine-inhaler-due-to-short-fill-hazard. Based on FDA recall #D-0176-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0176-2023%22&limit=1).

Nephron Sc Inc voluntarily recalled S2 Racepinephrine Inhalation Solution due to a short fill hazard, according to the FDA on Jan. 13, 2023. The recall affects 925,920 vials distributed nationwide and in Puerto Rico.

How to tell if you have it

  • Brand: Nephron Sc
  • Product: S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch
  • NDC: 0487-5901-99
  • UPC: 3 04875 90199 9
  • Lot codes: 126461, 126431
  • Expiration date: 04/30/2023

The hazard

The product contains a short fill. The FDA classified the recall as Class II.

Context

GovInfoNow's records show Nephron Sc Inc has issued three other recalls since Aug. 10, 2022. On Feb. 23, 2023, the company recalled Sterile Water for Injection due to potential product carryover hazards from CGMP deviations. Other recent recalls of similar products include Nephron Albuterol Inhaler (March 17, 2026) and American Regent Epinephrine Injection (Aug. 11, 2026).

How to tell if you have this one

Check for vials labeled 'S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch'. The lot numbers 126461 or 126431 with expiration 04/30/2023 are affected.

  • Brand
    Nephron Sc
  • Product
    S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide within the United States including Puerto Rico. Guatamala
Recall numberProduct, codes & lotsQuantityNDC
D-0175-2023Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4; Lot #: 126451 Exp. 04/30/2023387,000 vials—
D-0176-2023S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch, Manufactured By: Nephron West Columbia, SC 29172, NDC 0487-5901-99 UPC 3 04875 90199 9; Lot #: 126461, 126431 Exp. 04/30/2023925,920 vials0487-5901-99
Based on the official FDA remedy

What to do — step by step

  1. Check Vial Details

    Look for the lot numbers 126461 or 126431 and expiration date 04/30/2023 on the vial packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide within the United States including Puerto Rico. Guatamala” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

1. Firm started the recall: Jan 13, 202312. FDA classified it Class II: Jan 23, 202323. Published in FDA’s Enforcement Report: Feb 1, 202334. FDA terminated the recall: Oct 11, 2024420232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0176-2023 (January 13, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0176-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA